A215570 Stock Overview
Cronex Co., Ltd. engages in the research and development of medicines and raw materials for medical research.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cronex Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩880.00 |
| 52 Week High | ₩2,635.00 |
| 52 Week Low | ₩601.00 |
| Beta | 0 |
| 1 Month Change | -16.19% |
| 3 Month Change | 10.00% |
| 1 Year Change | -45.98% |
| 3 Year Change | -73.57% |
| 5 Year Change | -87.72% |
| Change since IPO | -85.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| A215570 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 13.7% | 1.7% | 0.5% |
| 1Y | -46.0% | 2.1% | 4.7% |
Return vs Industry: A215570 underperformed the KR Life Sciences industry which returned 2.1% over the past year.
Return vs Market: A215570 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A215570 volatility | |
|---|---|
| A215570 Average Weekly Movement | 16.4% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A215570's share price has been volatile over the past 3 months.
Volatility Over Time: A215570's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Young-Joon Son | www.cronex.co.kr |
Cronex Co., Ltd. engages in the research and development of medicines and raw materials for medical research. It provides non-clinical efficacy assessment services for the development of new drug and medical device prototypes; and lab animals for medical and laboratory use, as well as raw materials for dissimilar biomaterials replacing human tissue. The company was incorporated in 2012 and is headquartered in Hwaseong, South Korea.
Cronex Co., Ltd. Fundamentals Summary
| A215570 fundamental statistics | |
|---|---|
| Market cap | ₩2.81b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A215570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A215570 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A215570 perform over the long term?
See historical performance and comparison